Navigation Links
Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts
Date:9/16/2008

September 16, 2008 Studies published in a special issue of the online journal Sexuality Research and Social Policy by the University of California Press reveal that abstinence-only-until-marriage sex education programs fail to change sexual behavior in teenagers, provide inaccurate information about condoms, and violate human rights principles. Edited by John S. Santelli, MD, MPH, professor and chair of the Heilbrunn Department of Family and Population Health and Leslie M. Kantor, MPH, assistant professor of clinical Population and Family Health at the Columbia University Mailman School of Public Health, the theme issue examines scientific and ethical implications of federal abstinence-only policies and programs. To access the articles in this issue: http://caliber.ucpress.net/toc/srsp/5/3

In sum, the articles show that abstinence-only programs contain medical inaccuracies, fail to help young people to change behavior, and conflict with ethical standards. Abstinence-only programs violate young people's right to accurate informationand also teachers' and health educators' rights to answer questions and provide medically accurate information. Many states have now refused to participate in the federal program (25 states as of August 2008) citing concerns about efficacy and accuracy of abstinence-only programs. The federal program provides funding for abstinence-only education and restricts information about contraception and other aspects of human sexuality.

"Abstinence-only programs have a broad variety of problems with accuracy, efficacy, and ethics," Dr. Santelli. "These studies clearly demonstrate that federal promotion of abstinence has failed in its primary goal of helping young people delay initiation of sex, and actually, withholds life-saving information from young people."

"Many states are rejecting abstinence-only funding often over concerns about medical acc
'/>"/>

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
2. Overcoming inhibitors of cell death improves cancer therapy efficacy
3. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
4. A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohns Disease Drug Market
5. USC researchers identify genetic markers that predict efficacy of novel cancer drug
6. Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine on Stroke Victims
7. Pilot Study to Assess Safety and Efficacy of Medidur(TM) FA in AMD Patients Treated With Lucentis(R)
8. Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms
9. Efficacy of FluMist(R) in Children Highlighted at Pediatric Academic Societies Meeting
10. Labopharm Appeals FDAs Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
11. Gamma Secretase Modulators Show Promise in Alzheimers Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Drinking Your Way to Health 3F Perhaps Not 59700 1Drinking Your Way to Health 3F Perhaps Not 59700 2Drinking Your Way to Health 3F Perhaps Not 59700 3UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 1UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 2UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 3UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 4UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 5UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 6UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 7UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 8UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 9UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 10UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 11UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 12Video Games Can Play Havoc With Kids Joints 59696 1Video Games Can Play Havoc With Kids Joints 59696 2Video Games Can Play Havoc With Kids Joints 59696 3